Literature DB >> 7440977

Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study.

G Füst, M Kavai, G Szegedi, K Meretey, A Falus, A Lenkey, M Misz.   

Abstract

Forty serum samples of healthy blood donors and 60 sera of SLE patients were tested in parallel by 7 different assays for detecting immune complexes. Significantly higher titres and significant higher incidence of positive results were observed in the patient group than in the control group in 6 tests. No test discriminated between patients in an active stage of the disease and those whose disease was inactive. Significantly higher immune complex levels were found in lupus nephritis than in the non-nephritic patients by the complement consumption test. Significant positive correlation was obtained between the results of the macrophage aggregated IgG uptake inhibition and PEG-precipitation tests and between two tests based on the interaction of the complexes with the complement system. A characteristic 'profile' of the immune complex assay was observed in the course of the repeated testings of the same patients. The results indicate that the different methods detect different types of immune complexes present in the blood of the patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440977     DOI: 10.1016/0022-1759(80)90276-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).

Authors:  I Csípö; E Kiss; P Soltész; P Antal-Szalmás; G Szegedi; J H Cohen; R P Taylor; M Kávai
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.

Authors:  J F Tsai; J H Tsai; W Y Chang
Journal:  Gastroenterol Jpn       Date:  1990-06

3.  Significance of circulating immune complexes in pulmonary tuberculosis.

Authors:  A M Samuel; M D Ashtekar; R D Ganatra
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

4.  Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.

Authors:  G V Patel; R Gopal; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.

Authors:  H H Euler; P Kern; H Löffler; M Dietrich
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

6.  Signals of monocyte activation in patients with SLE.

Authors:  M Kávai; A Zsindely; I Sonkoly; M Major; I Demján; G Szegedi
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Helena Tyden; Christian Lood
Journal:  Arthritis Res Ther       Date:  2020-05-29       Impact factor: 5.156

8.  Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.

Authors:  J F Tsai; J E Jeng; M S Ho; W Y Chang; Z Y Lin; J H Tsai
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.